Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Inventory (2020 - 2025)

Neuroone Medical Technologies' Inventory history spans 6 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Inventory fell 13.71% year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, down 13.71%, while the annual FY2025 figure was $871492.0, 66.93% down from the prior year.
  • Inventory reached $1.7 million in Q4 2025 per NMTC's latest filing, up from $871492.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.6 million in Q3 2024 to a low of $52182.0 in Q2 2021.
  • Average Inventory over 5 years is $1.0 million, with a median of $903554.0 recorded in 2022.
  • Peak YoY movement for Inventory: soared 1558.33% in 2021, then plummeted 66.93% in 2025.
  • A 5-year view of Inventory shows it stood at $229115.0 in 2021, then skyrocketed by 294.37% to $903554.0 in 2022, then surged by 78.04% to $1.6 million in 2023, then increased by 20.03% to $1.9 million in 2024, then dropped by 13.71% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Inventory are $1.7 million (Q4 2025), $871492.0 (Q3 2025), and $793383.0 (Q2 2025).